» Articles » PMID: 1248919

Influence of Diabetes Mellitus on Drug Metabolism in Man

Overview
Specialties Pharmacology
Pharmacy
Date 1976 Jan 1
PMID 1248919
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Drug metabolizing capacity was assessed in 29 normal subjects and in 28 diabetics on various treatment regimes using the rate of antipyrine elimination as reflux. Plasma half-life of antipyrine was markedly shorter (38%), and the plasma clearance of this drug greater (40%) in diabetics receiving insulin than in controls. There was also an indication of a small increase in rate of test drug elimination in diabetics taking chlorpropamide. Patients being controlled solely on diet or those on tolbutamide did not exhibit an altered rate of drug elimination. The rate of metabolism and inactivation of other drugs may be altered in diabetics taking insulin so that optimal doses of some comcomitantly administered drugs may be different in this group of patients.

Citing Articles

Safety and Tolerability of Six Months of Isoniazid Plus Pyridoxine or Three Months of Rifampicin for Tuberculosis among Subjects with Diabetes Mellitus: A Randomized Trial.

Tamez-Torres K, Mongua-Rodriguez N, Ferreyra-Reyes L, Torres-Gonzalez P, Delgado-Sanchez G, Martinez-Hernandez M Microorganisms. 2023; 11(8).

PMID: 37630477 PMC: 10459081. DOI: 10.3390/microorganisms11081917.


Effect of diabetes mellitus on pharmacokinetic and pharmacodynamic properties of drugs.

Dostalek M, Akhlaghi F, Puzanovova M Clin Pharmacokinet. 2012; 51(8):481-99.

PMID: 22668340 DOI: 10.2165/11631900-000000000-00000.


Disposition of lorazepam in diabetes: differences between patients treated with beef/pork and human insulins.

Herman R, Chaudhary A, Szakacs C, Woo D, Lane R, Boctor M Eur J Clin Pharmacol. 1995; 48(3-4):253-8.

PMID: 7589050 DOI: 10.1007/BF00198307.


Differential effect of type I and type II diabetes on antipyrine disposition in man.

Zysset T, Wietholtz H Eur J Clin Pharmacol. 1988; 34(4):369-75.

PMID: 3402522 DOI: 10.1007/BF00542438.


Clinical pharmacokinetics and endocrine disorders. Therapeutic implications.

OConnor P, Feely J Clin Pharmacokinet. 1987; 13(6):345-64.

PMID: 3325214 DOI: 10.2165/00003088-198713060-00001.